	Oncological Care During a Crisis: A Systematic Review and Meta-Analysis of Non-Melanoma Skin Cancer of the Head and Neck Region in the COVID-19 Pandemic. Diseases Frosolini A, Benedetti S, Vaira LA, Gabriele G, Gennaro P. PMID: 42505582 [PubMed]
	Interleukin-1Î² Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case-Control Study. Curr Oncol Cauci S, Buligan C, Nacci P, Petris G, Stinco G. PMID: 42505240 [PubMed - indexed for MEDLINE]
	Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2. Curr Oncol Aboelatta MA, Zarka J, Tchatchua N, Aboelatta NA, Johnson JE, Jakub JW, Desroches J, Wilson-Miller J, Tabiim A, Behl D, Montane HN, Kottschade LA, Dimou A, Block MS, Heath EI, Doonan B, Seetharam M, Molina JR, Charnin JE, Gill P, Lin Y, Baral B, Markovic SN, Dudek AZ. PMID: 42505181 [PubMed - indexed for MEDLINE]
	Representation of melanoma depth staging with limited central section sampling: a retrospective simulation study. J Dtsch Dermatol Ges Pustelnik K, Tschandl P. PMID: 42503994 [PubMed - as supplied by publisher]
	Global patterns of melanoma, burden attributable to ultraviolet radiation exposure, and projections to 2050 across 185 countries: A population-based study with global modeling. JAAD Int Oh J, Kim S, Hwang SH, Son Y, Lee J, Kim J, López Sánchez GF, Pizzol D, Hwang J, Yon DK. PMID: 42502459 [PubMed]
	primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma. Eur J Cancer van Akkooi AC, Kicinski M, Govaerts AS, Hauschild A, Rutkowski P, Arenberger P, Ascierto PA, Tomczak P, Quereux G, De Galitiis F, Dutriaux C, Gebhardt C, Kapiteijn E, Machet L, Berciano MG, Del Vecchio M, Jalving M, Jouary T, Krajsova I, Matkovic S, Merelli B, Mortier L, Pagès-Laurent PL, Palmieri G, Pracht M, Vantuchova Y, Massi D, Elaut N, de Schaetzen G, Nuyens S, Jha N, Klauck I, Sansas B, Vedovato JC, Lorigan PC, Long GV, Eggermont AM, Mandala M. PMID: 42501621 [PubMed - as supplied by publisher]
	Epigenetic Modulators and Immunotherapy in Malignant Melanoma. Oncol Res Anestopoulos I, Kyriakou S, Deligiorgi M, Trafalis DT, Botaitis S, Franco R, Pappa A, Panayiotidis MI. PMID: 42500571 [PubMed - indexed for MEDLINE]
	CD40 Agonist Therapy in Melanoma: Translating Preclinical Promise Into Clinical Practice. Pigment Cell Melanoma Res Wei X, Li Y, Gao D. PMID: 42499227 [PubMed - indexed for MEDLINE]
	Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021. Medicine (Baltimore) Zhang R, Zhao Y, Li Y. PMID: 42499059 [PubMed - indexed for MEDLINE]
	A Case Report of Metastatic Melanoma of Unknown Primary with Massive Jejunal Involvement Mimicking Intestinal Lymphoma in a Young Adult: Diagnostic Pitfalls and Surgical Challenges. Reports (MDPI) Caziuc A, Ilie, Golea GI, Bibu-Monu, Deac AL, Dindelegan GC. PMID: 42496516 [PubMed]
	Non-Melanocytic Histopathological Clues for Melanoma Diagnosis: A Practical Review of Solar Elastosis, Stromal Regression, and Epidermal Reaction Patterns. Do Old-School Clues Still Matter? Dermatopathology (Basel) Sofopoulos M. PMID: 42496238 [PubMed]
	Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. Front Immunol Sequero-Lopez S, Castillo-Barnes D, Gálvez-Carvajal L, Palazón-Carrión N, Martínez-Murcia FJ, de la Cruz-Merino L, Muñoz-Couselo E, Provencio M, Ortiz A, Górriz JM, Ramírez J, Rueda-Domínguez A, Blancas I. PMID: 42495619 [PubMed - indexed for MEDLINE]
	AI-assisted diagnosis of nail unit melanoma and melanonychia using a clinical deep learning model. J Dtsch Dermatol Ges Chu Y, Yang S, Jung JW, Kim JY, Kim JG, Sung HJ, Oh B. PMID: 42494241 [PubMed - as supplied by publisher]
	A global perspective on prognosis in acral and non-acral cutaneous melanoma: A systematic review and meta-analysis. J Chin Med Assoc Huang CH, Lee KH, Chu PY, Li CY, Wang TH, Ma H, Chiu YJ. PMID: 42487166 [PubMed - as supplied by publisher]
	Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways. Int J Stem Cells Choi H, Lee JH, Cha HJ, Shin Y, Choi S. PMID: 42486780 [PubMed - as supplied by publisher]
	Inflammaging in melanoma: Precision control for optimizing immune checkpoint inhibition. J Dermatol Sci Kanemaru H, Luong S, Mizukami Y, Fukushima S, Ito F. PMID: 42486717 [PubMed - as supplied by publisher]
	Undifferentiated and Dedifferentiated Melanoma of the Genitourinary Tract: A Case Series Demonstrating the Potential for Diagnostic Pitfalls. Int J Surg Pathol Repetto F, Russell-Goldman EE, Duncan L, Dias-Santagata D, Odintsov I, Acosta AM, Chebib I, Oliva E, Wu CL, Hirsch MS. PMID: 42484487 [PubMed - as supplied by publisher]
	An unusual case of pancreatic metastasis from malignant melanoma. The diagnostic work-up to arrive at a final diagnosis. Prz Gastroenterol Massara M, Christakos E, Mulita F, Liolis E, Leivaditis V, Tasios K, Fergadis E, Hardavella G, Konstantellou E, Stefanidis K. PMID: 42483624 [PubMed]
	Delayed diagnosis of metastatic melanoma reoccurrence: Case report. J Family Med Prim Care Berg SW, Munns SE. PMID: 42483333 [PubMed]
	Immune-Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex). Cancer Med Iessa K, Kantilal K, Garekyaragh I, Paget L, Mangan Y, Shamsaldeen YA. PMID: 42482656 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 46034

Page 1 of 2302



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy